William H Herman Selected Research

4-nitro-3-dimethylaminopropiophenone

10/2021	Use of metformin following a population-level intervention to encourage people with pre-diabetes to enroll in the National Diabetes Prevention Program.
1/2021	The Effectiveness of a Proactive, Three-Level Strategy to Identify People With Prediabetes in a Large Workforce With Employer-Sponsored Health Insurance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

William H Herman Research Topics

Disease

57	Type 2 Diabetes Mellitus (MODY) 04/2022 - 10/2002
15	Obesity 06/2022 - 08/2006
14	Glucose Intolerance 05/2020 - 02/2003
13	Insulin Resistance 01/2021 - 10/2002
10	Hypertension (High Blood Pressure) 01/2022 - 03/2002
10	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 01/2004
9	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 03/2002
9	Stroke (Strokes) 01/2022 - 12/2002
9	Hypoglycemia (Reactive Hypoglycemia) 01/2022 - 01/2006
9	Heart Failure 01/2021 - 12/2002
8	Prediabetic State (Prediabetes) 01/2021 - 10/2013
8	Myocardial Infarction 01/2021 - 12/2005
7	Peripheral Nervous System Diseases (PNS Diseases) 01/2022 - 08/2006
7	Diabetes Complications 03/2016 - 08/2003
6	Chronic Kidney Failure (Chronic Renal Failure) 10/2018 - 03/2003
6	Hyperglycemia 01/2018 - 03/2008
6	Diabetes Mellitus 01/2017 - 05/2003
6	Human Influenza (Influenza) 11/2014 - 07/2004
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 01/2004
5	Weight Loss (Weight Reduction) 01/2020 - 01/2008
5	Overweight 04/2019 - 11/2007
5	Dyslipidemias (Dyslipidemia) 01/2015 - 10/2002
5	Weight Gain 02/2011 - 12/2006
4	Albuminuria 11/2018 - 03/2002
4	Body Weight (Weight, Body) 12/2017 - 06/2009
4	Proteinuria 09/2009 - 03/2002
3	Morbid Obesity 01/2020 - 01/2015
3	Gestational Diabetes (Gestational Diabetes Mellitus) 10/2018 - 12/2006
3	Diabetic Retinopathy (Retinopathy, Diabetic) 06/2013 - 12/2005
3	Diabetic Nephropathies (Diabetic Nephropathy) 07/2010 - 08/2003
2	Metabolic Diseases (Metabolic Disease) 06/2022 - 01/2021
2	Hemoglobinopathies 01/2019 - 07/2008
2	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 12/2016 - 10/2003
2	Ulcer 01/2016 - 06/2013
2	Hemiplegia (Spastic Hemiplegia) 05/2013 - 11/2012
2	Coronary Disease (Coronary Heart Disease) 05/2013 - 06/2012
2	Diabetic Neuropathies (Diabetic Neuropathy) 11/2012 - 08/2010
2	Peripheral Vascular Diseases (Peripheral Vascular Disease) 11/2012 - 08/2003
2	Foot Ulcer 10/2007 - 12/2002
1	Kidney Diseases (Kidney Disease) 04/2022
1	Tooth Loss 01/2022
1	Abdominal Obesity 01/2022
1	Lower Urinary Tract Symptoms 01/2021

Drug/Important Bio-Agent (IBA)

37	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 02/2003
30	Insulin (Novolin)FDA Link 01/2022 - 08/2003
18	Metformin (Glucophage)FDA LinkGeneric 10/2021 - 10/2002
17	Hemoglobins (Hemoglobin)IBA 01/2022 - 04/2007
13	Hypoglycemic Agents (Hypoglycemics)IBA 04/2022 - 05/2003
9	Rosiglitazone (Avandia)FDA Link 05/2011 - 10/2002
8	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 07/2004
6	LDL CholesterolIBA 01/2022 - 06/2003
6	Triglycerides (Triacylglycerol)IBA 01/2022 - 06/2010
6	Insulin Glargine (Lantus)FDA Link 07/2011 - 07/2005
6	Glyburide (Glibenclamide)FDA LinkGeneric 05/2011 - 10/2002
6	LipidsIBA 09/2009 - 07/2004
5	CreatinineIBA 01/2022 - 03/2002
5	HDL CholesterolIBA 01/2022 - 01/2004
5	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021 - 12/2006
5	Blood Glucose (Blood Sugar)IBA 01/2020 - 01/2006
5	Pharmaceutical PreparationsIBA 01/2020 - 10/2002
5	Insulin Lispro (Humalog)FDA Link 07/2011 - 07/2005
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022 - 03/2003
4	AlbuminsIBA 01/2021 - 10/2002
4	ThiazolidinedionesIBA 01/2020 - 12/2006
4	Antihypertensive Agents (Antihypertensives)IBA 01/2019 - 03/2003
4	Retinaldehyde (Retinal)IBA 09/2009 - 07/2004
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2005
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 06/2003
3	omega-Chloroacetophenone (Mace)IBA 01/2021 - 01/2020
3	empagliflozinIBA 01/2020 - 07/2018
3	Exenatide (Byetta)FDA Link 12/2011 - 01/2011
3	C-Reactive ProteinIBA 01/2010 - 10/2002
2	AdipokinesIBA 06/2022 - 01/2021
2	Angiotensin Receptor AntagonistsIBA 01/2022 - 08/2006
2	4-nitro-3-dimethylaminopropiophenoneIBA 10/2021 - 01/2021
2	CanagliflozinIBA 01/2020 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 10/2013 - 01/2010
2	1,5-anhydroglucitolIBA 06/2012 - 05/2009
2	SuspensionsIBA 07/2011 - 02/2011
2	2,4-thiazolidinedione (thiazolidinedione)IBA 07/2011 - 07/2010
2	Protamines (Protamine Sulfate)FDA Link 07/2011 - 02/2011
2	CholesterolIBA 01/2010 - 08/2006
2	AntigensIBA 08/2006 - 10/2002
2	Fibrinogen (Factor I)FDA Link 08/2006 - 10/2002
2	Losartan (Cozaar)FDA LinkGeneric 01/2006 - 03/2003
2	Angiotensin IIIBA 01/2006 - 03/2003
1	PhenolsIBA 06/2022
1	ParabensIBA 06/2022
1	CytokinesIBA 06/2022
1	NAD (NADH)IBA 01/2022
1	Clopidogrel (Plavix)FDA Link 01/2022
1	AndrogensIBA 01/2021

Therapy/Procedure

24	Therapeutics 01/2022 - 03/2003
21	Glycemic Control 01/2022 - 10/2002
7	Bariatric Surgery 01/2017 - 07/2010
5	Surgical Amputation (Amputations) 01/2022 - 12/2002
5	Injections 01/2017 - 07/2005
2	Drug Therapy (Chemotherapy) 01/2022 - 12/2006
2	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2018 - 12/2016
1	Secondary Prevention 01/2022